A Comparative Study on Two Cationic Porphycenes: Photophysical and Antimicrobial Photoinactivation Evaluation

Rubén Ruiz-González1, Montserrat Agut2, Elena Reddi3

  • 1Institut Químic de Sarrià, Universitat Ramon Llull, via Augusta 390, E-08017 Barcelona, Spain. ruben.ruiz@iqs.url.edu.

Insights

Two porphycene compounds show similar effectiveness in antimicrobial photodynamic therapy (aPDT) against resistant microbes. Modifications to their structure did not significantly alter their cell binding or photoinactivation capabilities.

Area of Science:

  • Photochemistry
  • Microbiology
  • Materials Science

Background:

  • Rising antimicrobial resistance necessitates novel therapeutic strategies.
  • Antimicrobial photodynamic therapy (aPDT) offers a promising alternative to conventional antibiotics.
  • Porphycene derivatives are being investigated as photosensitizers for aPDT.

Purpose of the Study:

  • To compare the photoinactivation efficiency of two aryl tricationic porphycenes against model pathogenic microorganisms.
  • To correlate the photophysical properties of porphycene derivatives with their antimicrobial efficacy.
  • To assess the binding extent of photosensitizers to bacterial cells.

Main Methods:

  • Comparative study of two aryl tricationic porphycenes.
  • Assessment of photoinactivation efficiency against model pathogenic microorganisms.
  • Flow cytometry used to quantify photosensitizer cell binding to bacteria.

Main Results:

  • Peripheral substituent changes in the tricationic porphycenes did not significantly impact their overall behavior.
  • Both compounds exhibited similar photokilling efficiency against tested microorganisms.
  • No significant difference was observed in the binding of the two porphycene derivatives to bacterial cells.

Conclusions:

  • Aryl tricationic porphycenes demonstrate comparable efficacy in antimicrobial photodynamic therapy.
  • Structural modifications on the periphery of these porphycenes do not substantially alter their antimicrobial performance or cellular uptake.
  • These findings contribute to the development of new antimicrobial agents to combat drug-resistant pathogens.